Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Servier
Sort By
Newest First
1 / 1
Sign in
1 / 1
Paris Sites And Digital Solutions
Nigel Walker
Nice Insight
PA1152
Dec 09, 2020
Servier Acquires Symphogen
Servier
PR-M04-20-NI-006
Apr 03, 2020
Business Models
CDMO Services Designed to Support Evolving Pharma Business Models
Patrice Martin
Servier
PAP-Q1-20-CL-007
Mar 19, 2020
Collaboration
Cellectis and Servier Execute the Amendment Confirming the Expansion of Their Collaboration on UCART19 Products
Servier
PR-M03-20-NI-008
Mar 05, 2020
Corporate Social Responsibility
Giving Structure to a Long-Term CSR Strategy
Vincent Minvielle
Servier
PAP-Q4-19-CL-030
Dec 06, 2019
Containment
Meeting the Need for Higher Containment
Suzanne Greene
Servier
PAP-Q3-19-CL-025
Oct 28, 2019
Serialization Update
Revisiting the Global Serialization Landscape
Michael Kinsella
Servier
PAP-Q2-2019-CL-030
May 24, 2019
Expansion
Servier Cuts Ribbon on New Boston Headquarters
Servier
PR-M05-19-NI-037
May 13, 2019
Outsourcing
Aligning the Outsourcing Relationship
Servier
PAP-Q1-2019-CL-006
Apr 12, 2019
Collaboration
Amgen, Cytokinetics And Servier Announce Continuation Of GALACTIC-HF Following Planned Interim Analysis
Amgen
PR-M03-19-NI-057
Mar 21, 2019
DCAT '19
Highly Potent API and Sterile Capabilities Key to DCAT Week ‘19 Company Announcements
David Alvaro, Ph.D.
Pharma's Almanac
PAO-M03-19-NI-024
Mar 18, 2019
Collaboration
Amgen, Cytokinetics and Servier Announce Start Of METEORIC-HF, The Second Phase 3 Clinical Trial Of Omecamtiv Mecarbil In Patients With Heart Failure
Amgen
PR-M02-19-NI-052
Feb 22, 2019
